Publisher
Springer Science and Business Media LLC
Reference11 articles.
1. Rodrigo JP, Hernandez-Prera JC, Randolph GW, Zafereo ME, Hartl DM, Silver CE, Suárez C, Owen RP, Bradford CR, Mäkitie AA, Shaha AR, Bishop JA, Rinaldo A, Ferlito A. Parathyroid cancer: an update. Cancer Treat Rev. 2020. https://doi.org/10.1016/j.ctrv.2020.102012.
2. Berland Y, Olmer M, Lebreuil G, Grisoli J. Parathyroid carcinoma, adenoma and hyperplasia in a case of chronic renal insufficiency on dialysis. Clin Nephrol. 1982;18(3):154–8.
3. Kada S, Tanaka M, Yasoda A. Parathyroid carcinoma in a patient with secondary hyperparathyroidism and thyroid hemiagenesis: a case report and review of the literature. Ear Nose & Throat J. 2021;103(1):N25–30.
4. Asare EA, Sturgeon C, Winchester DJ, Liu L, Palis B, Perrier ND, Evans DB, Winchester DP, Wang TS. Parathyroid carcinoma: an update on treatment outcomes and prognostic factors from the National Cancer Data Base (NCDB). Ann Surg Oncol. 2015;22:3990–5.
5. Ullah A, Khan J, Waheed A, Sharma N, Pryor EK, Stumpe TR, Zarate LV, Cason FD, Kumar S, Misra S, Kavuri S, Mesa H, Roper N, Foroutan S, Karki NR, Rivero JD, Simonds WF, Karim NA. Parathyroid carcinoma: incidence, survival analysis, and management: a study from the SEER database and insights into future therapeutic perspectives. Cancers (Basel). 2022. https://doi.org/10.3390/cancers14061426.